1. Home
  2. PXLW vs FEMY Comparison

PXLW vs FEMY Comparison

Compare PXLW & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PXLW
  • FEMY
  • Stock Information
  • Founded
  • PXLW 1997
  • FEMY 2004
  • Country
  • PXLW United States
  • FEMY United States
  • Employees
  • PXLW N/A
  • FEMY N/A
  • Industry
  • PXLW Semiconductors
  • FEMY Medical/Dental Instruments
  • Sector
  • PXLW Technology
  • FEMY Health Care
  • Exchange
  • PXLW Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • PXLW 28.1M
  • FEMY 31.9M
  • IPO Year
  • PXLW 2000
  • FEMY 2021
  • Fundamental
  • Price
  • PXLW $7.99
  • FEMY $0.95
  • Analyst Decision
  • PXLW Strong Buy
  • FEMY Strong Buy
  • Analyst Count
  • PXLW 2
  • FEMY 3
  • Target Price
  • PXLW $15.00
  • FEMY $8.67
  • AVG Volume (30 Days)
  • PXLW 73.1K
  • FEMY 262.9K
  • Earning Date
  • PXLW 08-06-2025
  • FEMY 08-07-2025
  • Dividend Yield
  • PXLW N/A
  • FEMY N/A
  • EPS Growth
  • PXLW N/A
  • FEMY N/A
  • EPS
  • PXLW N/A
  • FEMY N/A
  • Revenue
  • PXLW $34,246,000.00
  • FEMY $1,699,232.00
  • Revenue This Year
  • PXLW $5.21
  • FEMY $231.84
  • Revenue Next Year
  • PXLW $35.68
  • FEMY $245.28
  • P/E Ratio
  • PXLW N/A
  • FEMY N/A
  • Revenue Growth
  • PXLW N/A
  • FEMY 61.97
  • 52 Week Low
  • PXLW $4.67
  • FEMY $0.69
  • 52 Week High
  • PXLW $14.16
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • PXLW 60.10
  • FEMY 46.82
  • Support Level
  • PXLW $6.71
  • FEMY $0.90
  • Resistance Level
  • PXLW $7.67
  • FEMY $0.99
  • Average True Range (ATR)
  • PXLW 0.52
  • FEMY 0.06
  • MACD
  • PXLW 0.02
  • FEMY 0.00
  • Stochastic Oscillator
  • PXLW 66.67
  • FEMY 18.18

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: